AgomAb Therapeutics NV (AGMB) Stock Price & Financial Analysis
AgomAb Therapeutics NV Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About AgomAb Therapeutics NV
What is the current stock price for AGMB?
As of the latest trading session, AGMB stock trades at $10.51. The 52-week range is $9.00–$17.45, with a day range of $10.23–$10.70.
What is the P/E ratio for AGMB?
The P/E ratio (Price-to-Earnings) for AGMB is shown in the Key Statistics section. This valuation metric helps compare AgomAb Therapeutics NV to industry peers.
Does AGMB pay dividends?
AgomAb Therapeutics NV does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AGMB?
Based on 3 analysts, the consensus for AGMB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of AGMB?
AgomAb Therapeutics NV's market capitalization is $5.7M, classifying it as a micro-cap company. AgomAb Therapeutics NV operates in the Healthcare sector within the Biotechnology industry.